ClinicalTrials.gov
public full text
Public Domain
A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects
This is a randomised, double-blind, positive drug parallel controlled clinical trial in China. In the trial, it is planned to enroll 88 subjects, randomized to two treatment groups in a ratio of 1:1 to receive the test drug and the positive control.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tezepelumab Phase 1 PK Study in Healthy Chinese Subjects#1008309
- DDI Study of Evobrutinib and Carbamazepine#1093433
- Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s#1102979
- PK Study of Gefurulimab SC in Healthy Chinese Adult Participants#1100953
- The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China#442086
Record · ID 837717
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive